Indomethacin vs pancreatic stent to prevent post-ERCP pancreatitis
Treatments studied
Part of Digestive system clinical trials.
This study compares indomethacin (an anti-inflammatory medicine) against using a temporary pancreatic stent to prevent pancreatitis after an ERCP procedure. It may help you lower the chance of painful inflammation of the pancreas after ERCP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having an ERCP soon and have at least one risk factor for post-ERCP pancreatitis
- Your risk factor can include prior pancreatitis after ERCP, difficult access with many attempts, or other listed features
- You do not already need a pancreatic stent for another reason (like pancreatic duct narrowing or ampullectomy)
- You must be age 18 or older and able to give informed consent
- You cannot be pregnant or breastfeeding
- You should not have a reason you cannot take NSAIDs (like indomethacin), such as active stomach bleeding, kidney failure, NSAID allergy, or early heart failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a low dose of indomethacin (a pain reliever) with the standard dose to see if it works just as well for preventing pancreatitis (inflammation of the pancreas) after an ERCP procedure. It may reduce side effects while still protecting your pancreas.
This trial is testing whether higher doses of a common anti-inflammatory drug (indomethacin) given as a suppository can better prevent pancreatitis after an ERCP procedure in people who are at high risk for this complication.
This study tests whether a rectal suppository of indomethacin (a type of anti-inflammatory) can help prevent complications during a bile duct procedure called ERCP. It's for people who have already had a prior bile duct cut.
This trial tests placing a small plastic tube (stent) in your pancreatic duct early during ERCP to try to prevent pancreatitis (inflammation of the pancreas). It’s for people having their first ERCP to get into their bile duct.
This trial looks at how often a small pancreatic stent (a plastic tube placed during an ERCP procedure) dislodges or causes problems. It may help patients who are getting a stent to prevent pancreatitis.
This trial tests whether giving extra IV fluids before, during, and after an ERCP procedure can help prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). If you are scheduled for an ERCP, you may be eligible to participate.
Hear when a new Post-ERCP Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.